My watch list
my.bionity.com  
Login  

Patho-biotechnology



The term Patho-biotechnology [1] [2] [3], coined by Dr Roy Sleator and Prof Colin Hill (University College Cork, Ireland) describes the exploitation of pathogenic stress survival factors in biotechnology, medicine and food.

This approach shows promise for the development of novel vaccine and drug delivery systems, as well as the design of more technologically robust and effective probiotic cultures with improved biotechnological and clinical applications.

References

  1. ^ Sleator RD and C Hill. 2007. Patho-biotechnology; using bad bugs to make good bugs better. Science Progress. 90, 1-14.
  2. ^ Sleator RD and C Hill. 2006. Patho-biotechnology; using bad bugs to do good things. Current Opinion in Biotechnology. 17, 211-216.
  3. ^ Sleator RD and Hill. 2007. 'Bioengineered Bugs' - A patho-biotechnology approach to probiotic research and applications. [doi:10.1016/j.mehy.2007.03.008]
  • Science Direct
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Patho-biotechnology". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE